The ultrasound system developer's Edwards Lifesciences-backed series B round will fund product development and commercial growth.

The network management technology provider, which counts Cisco, Dell, Salesforce, Deutsche Telekom and Telstra as investors, has now raised $125m in total.

Gilead Sciences returned for a $46.7m round that will support further development of its biosensor-based diagnostics device.

University of Toronto and McMaster University-founded glioblastoma Car T-cell therapy developer Empirca Therapeutics has been acquired by Century Therapeutics.

Telstra Ventures was among the investors in the equity portion of cloud data storage provider Nasuni's latest round, lifting its total equity funding to $169m.

University of Birmingham's cancer immunotherapy developer Revitope Oncology secured equity funding as part of a $160m alliance with Junshi Biosciences.

Exelon has chosen 10 climate change mitigation startups that will receive an initial $1m in funding as part of a $20m scheme.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The banking software provider's shares have nearly tripled following an offering in which it floated well above its range.

Salesforce Ventures led a $120m round for the identity management software provider that also attracted Deutsche Telekom and Telstra, at a valuation exceeding $1.9bn.